May 2026 Recall: Clinical Approach to Monocular Vision Loss

Neurology® Podcast1h 33mMay 1, 2026

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “May 2026 Recall: Clinical Approach to Monocular Vision Loss” inside PodZeus.

AI-Generated Summary

Monocular vision loss is not just a visual emergency—it's a neurovascular crisis requiring immediate, precise diagnosis and interdisciplinary collaboration. In this comprehensive Neurology® Podcast recall, neuro-ophthalmologists Nancy Newman and Valerie Buse from Emory University dismantle long-standing myths about central retinal artery occlusion (CRAO) and non-arteritic anterior ischemic optic neuropathy (NAION). They argue that CRAO is a true stroke of the retina, demanding the same urgency as cerebral infarction—'time is retina'—and that thrombolysis, though off-label, should be considered within 4.5 hours of vision loss, especially when imaging confirms the diagnosis. The episode exposes the dangerous gap between clinical intuition and diagnostic reality: most non-ophthalmologists cannot reliably diagnose CRAO with an ophthalmoscope, and point-of-care ultrasound is dangerously unreliable. Instead, the solution lies in deploying portable fundus cameras in emergency departments, enabling remote teleophthalmology and AI-assisted interpretation. For NAION, the podcast reveals a paradigm shift: it's not a simple 'stroke' but a compartment syndrome triggered by a congenitally crowded optic nerve head, with vascular risk factors and emerging drug associations—especially GLP-1 receptor agonists—now under intense scrutiny.

Key Takeaways
1

Diagnose CRAO with fundus photography or OCT—not an ophthalmoscope—because direct visualization is unreliable and delays care.

2

Time is retina: administer IV thrombolysis within 4.5 hours of vision loss if CRAO is confirmed by imaging, following stroke neurology protocols.

3

The risk of hemorrhage from IV thrombolysis in CRAO is low, and the benefit-risk threshold should be higher than for cerebral stroke due to vision's high personal value.

4

NAION is not a lacunar stroke; it's a compartment syndrome in a crowded optic nerve head, requiring evaluation of cup-to-disc ratio in the unaffected eye.

5

GLP-1 receptor agonists are associated with a modestly increased risk of NAION (likely <2x), but the absolute risk remains very low—do not screen all patients for optic nerve anatomy.

…and 3 more takeaways available in PodZeus

Chapters
0:00
3 min

Introduction to the Neurology Recall Series

Jeff Ratliff introduces the May 2026 Neurology Recall, a curated compilation of two-part series on monocular vision loss. The episode features interviews with Emory University neuro-ophthalmologists Nancy Newman and Valerie Buse on central and branch retinal artery occlusions (CRAO/BRAO) and non-arteritic anterior ischemic optic neuropathy (NAION).

2:37
14 min

The Clinical Diagnosis of CRAO: Why 'Time is Retina'

You need to have non-midgeriatric cameras in the emergency department that will allow the emergency department staff to take pictures themselves on every patient who presents with acute vision loss.

Highlight
17:00
21 min

Thrombolysis for CRAO: Off-Label but Logically Sound

We went from 17 to 65. I love it. I'm giving thrombolysis to everyone. I know I am for sure. Yeah, me too. The problem? is that in the control group... visual recovery was between 45 and 48%.

Highlight
37:30
20 min

The Limits of Current Trials and the Hope for Meta-Analysis

The truth is 65% versus 48%, I would still take it because they both showed that it was safe with one caveat.

Highlight
57:30
18 min

The Stroke Workup for CRAO: A Neurologist’s Responsibility

Nancy Newman and Valerie Buse challenge the outdated notion that carotid ultrasound is the first step. They assert that CRAO is a stroke and must be evaluated with a full stroke workup—ECG, cardiac monitoring for atrial fibrillation, and imaging—because the cause is often embolic, not carotid stenosis.

High-Impact Quotes
we went from 17 to 65. I love it. I'm giving thrombolysis to everyone. I know I am for sure. Yeah, me too. The problem? is that in the control group, which was 300 milligram oral aspirin, the
Nancy Newman33:52
Viral: 88.0
need to have non -media cameras in the emergency department that will allow the emergency department staff to take pictures themselves on every patient who presents with acute vision loss.
Valerie Buse48:28
Viral: 85.0
The risk of NAON was greater than four times greater in the diabetes patients who were on semaglutide and was greater than seven times more frequent in those patients on semaglutide who were overweight or obese and taking it for that reason.
Valerie Buse84:55
Viral: 80.0
Speakers

Hosts

Jeff RatliffDan AckermanJustin AbadamarcoJose MerinoStacey Clardy

Guests

Nancy NewmanValerie Buse
Topics Discussed
central retinal artery occlusion95%non-arteritic anterior ischemic optic neuropathy93%time is retina92%branch retinal artery occlusion90%GLP-1 receptor agonists88%fundus photography85%optical coherence tomography80%stroke workup75%
People & Brands

Nancy Newman

person

12xPositive

Valerie Buse

person

11xPositive

Emory University

organization

6xNeutral

Dan Ackerman

person

5xNeutral

Justin Abadamarco

person

4xNeutral

Hathaway et al.

other

3xNeutral

German revision trial

other

2xPositive

Kaiser Permanente

organization

2xPositive

Jeff Ratliff

person

2xNeutral

Jose Merino

person

2xNeutral

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “May 2026 Recall: Clinical Approach to Monocular Vision Loss” inside PodZeus.

Start discovering podcast insights today

Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.

No credit card required • 7-day trial • Cancel anytime